Skip to Content
Dai  Yamanouchi, MD, PhD

Contact Dr. Yamanouchi

E-mail:
yamano@surgery.wisc.edu

Phone:
(608) 265-4420

Mail:
600 Highland Ave
BX3236 CLINICAL SCIENCE CNTR
Madison, WI 53792

Dai Yamanouchi, MD, PhD

Assistant Professor
Division of Vascular Surgery

Education

  • MD, Gunma University, Japan, 2000
  • PhD, Gunma University, Japan, 2006
  • Surgical Internship and Residency, Gunma University Hospital, Japan, 2000-2003
  • Surgical Residency, Saiseikai Maebashi Hospital, Japan, 2001-2002
  • Research Fellowship, Nagoya University Graduate School of Medicine, Japan, 2003-2004
  • Clinical Fellowship in Vascular Surgery, Nagoya University Hospital, Japan, 2004-2007
  • Research Fellowship, Weill Cornell Medical College, New York, NY, 2007-2008
  • Fellowship in Advanced Endovascular Surgery, University of Wisconsin Madison, Madison, WI, 2009-2010

Clinical Specialties

Dr. Yamanouchi specializes in vascular and endovascular surgery. He is board certified in angiology and endovascular surgery in Japan.

Dr. Yamanouchi specializes in open and endovascular techniques for the treatment of vascular diseases. His expertise includes treatments for aortic aneurysms, carotid disease, aortic dissection, peripheral arterial disease, and other vascular disorders.

Dr. Yamanouchi provides a wide range of services including Abdominal Aortic Aneurysm (AAA) Repair - Endovascular, Abdominal Aortic Aneurysm (AAA) Repair - Open, Amputation, Angioplasty With Stent Placement, Carotid Endartecotomy, Carotid Stenting, Extended Efforts in Limb Salvage, Peripheral Artery Bypass, Thoracic Aortic Aneursym - Endovascular, Thoracic Aortic Aneursym - Open, Thoracic Outlet Syndrome Treatment, and Varicose Vein Treatment.

Research Interests

Dr. Yamanouchi’s research interests include the pathogenesis of abdominal aortic aneurysm and restenosis after angioplasty including balloon angioplasty and stent placement. He is also devoted to the development of novel materials for vascular bypass graft and gene delivery method to treat the patients who suffers peripheral arterial disease. In addition, Dr. Yamanouchi serves as principal investigator on a number of clinical trials.

Dr. Yamanouchi's Lab

Wisconsin Vascular and Endovascular Research Network (WiVERN)

Funding/Grants

Active Clinical Trials
  • A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy, Safety, And Tolerability Of Ixmyelocel-T In Subjects With Critical Limb Ischemia And No Options For Revascularization
    Principal Investigator(s): Dai Yamanouchi, MD, PhD
    Status: Active, not recruiting
    [ClinicalTrials.gov: NCT01483898]
    More Information

Recent Publications
  • Postdischarge outcomes after endovascular abdominal aortic aneurysm repair.
    Gupta PK, Engelbert TL, Ramanan B, Fang X, Yamanouchi D, Hoch JR, Acher CW
    J. Vasc. Surg. 2014 Apr; 59(4):903-8.
    [PubMed ID: 24360236]
    More Information
  • Current status of medical treatment for abdominal aortic aneurysm.
    Kurosawa K, Matsumura JS, Yamanouchi D
    Circ. J. 2013; 77(12):2860-6.
    [PubMed ID: 24161907]
    More Information
  • Aneurysmal disease: the abdominal aorta.
    Takayama T, Yamanouchi D
    Surg. Clin. North Am. 2013 Aug; 93(4):877-91, viii.
    [PubMed ID: 23885935]
    More Information
  • The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
    Matsumura JS, Yamanouchi D, Goldstein JA, Pollock CW, Bosiers M, Schultz GA, Scheinert D, Rocha-Singh KJ
    J. Vasc. Surg. 2013 Jul; 58(1):73-83.e1.
    [PubMed ID: 23642924]
    More Information
  • Balanced mineralization in the arterial system: possible role of osteoclastogenesis/osteoblastogenesis in abdominal aortic aneurysm and stenotic disease.
    Yamanouchi D, Takei Y, Komori K
    Circ. J. 2012; 76(12):2732-7.
    [PubMed ID: 23117745]
    More Information
  • Elevated protein kinase C-δ contributes to aneurysm pathogenesis through stimulation of apoptosis and inflammatory signaling.
    Morgan S, Yamanouchi D, Harberg C, Wang Q, Keller M, Si Y, Burlingham W, Seedial S, Lengfeld J, Liu B
    Arterioscler. Thromb. Vasc. Biol. 2012 Oct; 32(10):2493-502.
    [PubMed ID: 22879584, PMC ID: 3442600]
    More Information
  • Accelerated aneurysmal dilation associated with apoptosis and inflammation in a newly developed calcium phosphate rodent abdominal aortic aneurysm model.
    Yamanouchi D, Morgan S, Stair C, Seedial S, Lengfeld J, Kent KC, Liu B
    J. Vasc. Surg. 2012 Aug; 56(2):455-61.
    [PubMed ID: 22560311, PMC ID: 3408782]
    More Information
  • Transforming growth factor-β increases vascular smooth muscle cell proliferation through the Smad3 and extracellular signal-regulated kinase mitogen-activated protein kinases pathways.
    Suwanabol PA, Seedial SM, Shi X, Zhang F, Yamanouchi D, Roenneburg D, Liu B, Kent KC
    J. Vasc. Surg. 2012 Aug; 56(2):446-54.
    [PubMed ID: 22521802, PMC ID: 3408812]
    More Information
  • Results of carotid artery stenting with distal embolic protection with improved systems: Protected Carotid Artery Stenting in Patients at High Risk for Carotid Endarterectomy (PROTECT) trial.
    Matsumura JS, Gray W, Chaturvedi S, Yamanouchi D, Peng L, Verta P
    J. Vasc. Surg. 2012 Apr; 55(4):968-976.e5.
    [PubMed ID: 22236885]
    More Information
  • Delivery of plasmid DNA to vascular tissue in vivo using catheter balloons coated with polyelectrolyte multilayers.
    Saurer EM, Yamanouchi D, Liu B, Lynn DM
    Biomaterials 2011 Jan; 32(2):610-8.
    [PubMed ID: 20933275, PMC ID: 2991550]
    More Information

webmaster@surgery.wisc.edu Copyright © 2014 The Board of Regents of the University of Wisconsin System